Norges Bank’s CVS Health CVS Stock Holding History

Norges Bank’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,996,288	Closed	-$1.67B	–	361
2025 Q4	$1.67B	Buy	+20,996,288	New	+$1.66B	0.18%	101
2025 Q3	–	Sell	-19,696,987	Closed	-$1.36B	–	403
2025 Q2	$1.36B	Buy	19,696,987 +2,573,560	+15%	+$169M	0.17%	109
2025 Q1	$1.16B	Sell	17,123,427 -1,579,501	-8%	-$94.5M	0.16%	121
2024 Q4	$840M	Buy	18,702,928 +4,267,914	+30%	+$239M	0.11%	165
2024 Q3	$908M	Sell	14,435,014 -466,112	-3%	-$27.2M	0.13%	150
2024 Q2	$880M	Buy	14,901,126 +163,313	+1%	+$10.2M	0.13%	145
2024 Q1	$1.18B	Buy	14,737,813 +907,521	+7%	+$69.3M	0.19%	106
2023 Q4	$1.09B	Sell	13,830,292 -1,050,195	-7%	-$74.7M	0.19%	100
2023 Q3	$1.04B	Sell	14,880,487 -522,957	-3%	-$37.1M	0.21%	91
2023 Q2	$1.06B	Buy	15,403,444 +431,652	+3%	+$30.7M	0.21%	92
2023 Q1	$1.11B	Sell	14,971,792 -324,016	-2%	-$27.2M	0.24%	79
2022 Q4	$1.43B	Buy	15,295,808 +859,805	+6%	+$83M	0.34%	56
2022 Q3	$1.38B	Buy	14,436,003 +597,133	+4%	+$59.1M	0.37%	52
2022 Q2	$1.28B	Buy	13,838,870 +305,377	+2%	+$29.8M	0.33%	58
2022 Q1	$1.37B	Buy	13,533,493 +477,993	+4%	+$50.2M	0.3%	67
2021 Q4	$1.35B	Sell	13,055,500 -67,996	-0.5%	-$6.28M	0.28%	70
2021 Q3	$1.11B	Sell	13,123,496 -568,166	-4%	-$47.6M	0.25%	77
2021 Q2	$1.14B	Sell	13,691,662 -643,470	-4%	-$52.7M	0.25%	75
2021 Q1	$1.08B	Buy	14,335,132 +207,580	+1%	+$15.1M	0.25%	76
2020 Q4	$965M	Buy	14,127,552 +301,257	+2%	+$19.6M	0.23%	81
2020 Q3	$807M	Sell	13,826,295 -76,623	-0.6%	-$4.77M	0.21%	81
2020 Q2	$903M	Buy	13,902,918 +971,699	+8%	+$61.2M	0.26%	70
2020 Q1	$767M	Buy	12,931,219 +67,142	+0.5%	+$4.48M	0.27%	69
2019 Q4	$956M	Buy	12,864,077 +59,704	+0.5%	+$4.19M	0.27%	68
2019 Q3	$808M	Sell	12,804,373 -55,389	-0.4%	-$3.28M	0.25%	75
2019 Q2	$701M	Sell	12,859,762 -140,106	-1%	-$7.54M	0.22%	86
2019 Q1	$701M	Buy	12,999,868 +175,488	+1%	+$10.8M	0.23%	86
2018 Q4	$840M	Buy	12,824,380 +2,901,489	+29%	+$217M	0.31%	61
2018 Q3	$781M	Sell	9,922,891 -227,599	-2%	-$16.3M	0.25%	73
2018 Q2	$653M	Buy	10,150,490 +146,804	+1%	+$9.67M	0.22%	84
2018 Q1	$622M	Sell	10,003,686 -224,235	-2%	-$16.1M	0.23%	86
2017 Q4	$742M	Sell	10,227,921 -140,864	-1%	-$10.2M	0.27%	69
2017 Q3	$843M	Hold	10,368,785	–	–	0.32%	56
2017 Q2	$834M	Sell	10,368,785 -104,648	-1%	-$8.26M	0.33%	51
2017 Q1	$822M	Buy	10,473,433 +330,802	+3%	+$26.4M	0.34%	49
2016 Q4	$800M	Sell	10,142,631 -115,840	-1%	-$9.37M	0.35%	48
2016 Q3	$872M	Buy	10,258,471 +1,410,234	+16%	+$133M	0.41%	45
2016 Q2	$847M	Sell	8,848,237 -379,038	-4%	-$37.8M	0.4%	45
2016 Q1	$957M	Sell	9,227,275 -543,097	-6%	-$52.8M	0.47%	42
2015 Q4	$955M	Buy	9,770,372 +52,815	+0.5%	+$5.17M	0.47%	41
2015 Q3	$938M	Sell	9,717,557 -618,541	-6%	-$65M	0.49%	39
2015 Q2	$1.08B	Buy	10,336,098 +206,411	+2%	+$21.1M	0.54%	35
2015 Q1	$1.05B	Buy	10,129,687 +185,088	+2%	+$18.7M	0.51%	35
2014 Q4	$958M	Buy	9,944,599 +139,433	+1%	+$12.3M	0.49%	38
2014 Q3	$780M	Sell	9,805,166 -9,470,170	-49%	-$747M	0.42%	43
2014 Q2	$1.45B	Buy	19,275,336 +9,472,579	+97%	+$716M	0.39%	48
2014 Q1	$734M	Buy	9,802,757 +425,149	+5%	+$30M	0.41%	44
2013 Q4	$671M	Sell	9,377,608 -1,581,947	-14%	-$102M	0.39%	49
2013 Q3	$622M	Sell	10,959,555 -33,400	-0.3%	-$1.99M	0.36%	50
2013 Q2	$629M	Buy	+10,992,955	New	+$637M	0.39%	44

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank's CVS Position: Q1 2026 in Review

Norges Bank sold out of CVS Health (CVS) in Q1 2026, closing a stake of 20,996,288 shares — an estimated $1.67B sold.

Norges Bank first reported a position in CVS in Q2 2013 and held it in 50 quarters. The position peaked at $1.67B in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Norges Bank reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 20,996,288 CVS Health shares in Q1 2026, an estimated $1.67B.
Norges Bank first reported a position in CVS Health in Q2 2013 and held it in 50 quarters.
Norges Bank's CVS Health position peaked at $1.67B in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.